What is Speech Pathology Group?
Speech Pathology Group (SPGCT) is a woman-owned, multidisciplinary practice headquartered in Connecticut, dedicated to providing evidence-based therapy services for children and adults. Their extensive offerings encompass speech, occupational, physical, and feeding therapies, alongside applied behavior analysis. SPGCT prioritizes high-quality care, collaborative approaches, and robust family support, aiming to empower individuals and foster stronger communities. The practice serves families and school districts throughout Connecticut, with a commitment to accessible services through flexible financing options.
How much funding has Speech Pathology Group raised?
Speech Pathology Group has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Speech Pathology Group
PPP
Public-Private Partnership
What's next for Speech Pathology Group?
The substantial capital infusion, particularly the recent strategic investment, positions Speech Pathology Group for accelerated expansion and enhanced service delivery. As a company in a large-scale, late-stage funding phase, SPGCT is likely to focus on scaling its operations, potentially through geographic expansion, the integration of new therapeutic modalities, or further technological advancements to optimize patient care and administrative efficiency. This strategic backing signals confidence from investors in SPGCT's business model and its capacity for sustained growth in the competitive healthcare landscape.
See full Speech Pathology Group company page
